Welcome to the e-CCO Library!

DOP21: Potential mechanisms linking biological therapies on SARS-CoV-2 susceptibility in Inflammatory Bowel Disease patients
Year: 2022
Source: ECCO'22
Authors: Pisani, L.F.(1);Mola, S.(2,3);Crespi, G.(2,3);Caprioli, F.(4,5);Pastorelli, L.(6,7);Annunziata, M.L.(1);Manfredi, M.(3,8);Porta, C.(2,3);
Created: Friday, 11 February 2022, 3:52 PM
DOP21: Role of P2X7 in intestinal fibrosis and inflammasome activation: Relevance in Crohn´s Disease
Year: 2021
Source: ECCO'21 Virtual
Authors: Lis-López, L.(1);Bauset, C.(1);Ortiz-Masia, D.(1);Gisbert-Ferrándiz, L.(1);Coll, S.(1);Calatayud, S.(1);Barrachina, M.D.(1);Cosín-Roger, J.(2)
Created: Wednesday, 2 June 2021, 4:12 PM
DOP22 Certification of integral care IBD Units: Evaluation of a certification program (CUE)
Year: 2020
Source:

ECCO'20 Vienna

Authors:

M. Barreiro-de Acosta1, A. Gutierrez2, Y. Zabana3, B. Beltran4, X. Calvet5, M. Chaparro6, E. Domènech7, M. Esteve3, J. Panés8, J.P. Gisbert6, P. Nos4, on behalf of GETECCU

Created: Thursday, 30 January 2020, 10:12 AM
DOP22: Antibiotic Use as a Risk Factor for Inflammatory Bowel Disease Across the Ages: A Population-Based Cohort Study
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Adam Faye
Created: Friday, 14 July 2023, 2:22 PM
DOP22: Antibiotic Use as a Risk Factor for Inflammatory Bowel Disease Across the Ages: A Population-Based Cohort Study
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Faye, A.(1)*;Allin, K.(2);Iversen, A.(3);Agrawal, M.(4);Faith, J.(5);Colombel, J.F.(5);Jess, T.(2);
Created: Friday, 14 July 2023, 10:43 AM
DOP22: Certification of Integral Care IBD Units: Evaluation of a certification program (CUE)
Year: 2020
Source: ECCO'20 Vienna
Authors: Manuel Barreiro-de Acosta
Created: Tuesday, 23 June 2020, 5:40 PM
DOP22: Certification of Integral Care IBD Units: Evaluation of a certification program (CUE)
Year: 2020
Source: ECCO'20 Vienna
Authors: Manuel Barreiro-de Acosta
Created: Tuesday, 23 June 2020, 4:58 PM
Files: 1
DOP22: Clinical, biochemical and endoscopic disease activity of Inflammatory Bowel Diseases are not associated with the severity or long-term outcomes of COVID-19 – A Danish prospective population-based cohort study
Year: 2022
Source: ECCO'22
Authors: Attauabi, M.(1,2,3);Dahlerup, J.F.(4);Poulsen, A.(5);Hansen, M.R.(6);Vester-Andersen, M.K.(7);Eraslan, S.(2);Prahm, A.P.(5);Pedersen, N.(8);Larsen, L.(9);Jess, T.(9,10);Neumann, A.(11);Haderslev, K.V.(12);Molazahi, A.(13);Lødrup, A.B.(14);Glerup, H.(15);Oppfeldt, A.M.(16);Jensen, M.D.(17);Theede, K.(1,3);Kiszka-Kanowitz, M.(1,3);Seidelin, J.B.(2);Burisch, J.(1,3); Danish COVID-IBD Study Group
Created: Friday, 11 February 2022, 3:52 PM
DOP22: Integrative -omic analysis reveals microbiota mediated molecular mechanisms influencing host mucosal gene expression in Crohn’s Disease
Year: 2021
Source: ECCO'21 Virtual
Authors: Sudhakar, P.(1);Andrighetti, T.(2);Verstockt, S.(1);Caenepeel, C.(1,3);Ferrante, M.(1,3);Sabino, J.(1,3);Verstockt., B.(1,3);Vermeire, S.(1,3)
Created: Wednesday, 2 June 2021, 4:12 PM
DOP22: Predictive biomarkers of therapeutic response in Inflammatory Bowel Disease: a step towards personalized medicine.
Year: 2024
Source: ECCO'24 Stockholm
Authors: Baldan-Martin, Montserrat
Created: Tuesday, 30 April 2024, 5:03 PM
DOP22: UC-related and segment-specific properties of patient-derived colonic organoids
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

K. Suzuki*1, H. Shimizu1, M. Kawai1, J. Takahashi1, S. Anzai1, A. Kawamoto1, S. Nagata1, Y. Hiraguri1, S. Yui1, K. Tsuchiya1, T. Nakamura1, K. Ohtsuka1, K. Ohtsuka1, R. Okamoto1, M. Watanabe1

Created: Friday, 22 February 2019, 9:41 AM
DOP22: UC-related and segment-specific properties of patient-derived colonic organoids.
Year: 2019
Source: ECCO'19 Copenhagen
Authors: Kohei Suzuki
Created: Tuesday, 28 May 2019, 3:32 PM
Epithelial cell
Files: 1
DOP23 Endoscopic evaluation at 1 month after ileocolic resection for Crohn’s disease predicts postoperative recurrence and is safe
Year: 2020
Source:

ECCO'20 Vienna

Authors:

Z. Guo, Y. Zhu, L. Cao, Y. Li, Z. Wang, W. Zhu

Created: Thursday, 30 January 2020, 10:12 AM
DOP23: Decrements in quality of life associated with symptoms of Inflammatory Bowel Disease: results from the UK IBD-BOOST survey
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Chris Roukas
Created: Friday, 14 July 2023, 2:22 PM
DOP23: Decrements in quality of life associated with symptoms of Inflammatory Bowel Disease: results from the UK IBD-BOOST survey
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Roukas, C.(1)*;Miller , L.(2);Hamborg, T.(2);Gordeev, V.(1);Lindsay, J.(3);Norton, C.(4);Mihaylova, B.(1);
Created: Friday, 14 July 2023, 10:43 AM
DOP23: Long-term health consequences of COVID-19 in patients with Inflammatory Bowel Diseases – A Danish prospective population-based cohort study
Year: 2022
Source: ECCO'22
Authors: Attauabi, M.(1,2,3);Dahlerup, J.F.(4);Poulsen, A.(5);Hansen, M.R.(6);Vester-Andersen, M.K.(7);Eraslan, S.(2);Prahm, A.P.(5);Pedersen, N.(8);Larsen, L.(9);Jess, T.(9,10);Neumann, A.(11);Haderslev, K.V.(12);Molazahi, A.(13);Lødrup, A.B.(14);Glerup, H.(15);Oppfeldt, A.M.(16);Jensen, M.D.(17);Theede, K.(1,3);Kiszka-Kanowitz, M.(1,3);Seidelin, J.B.(2);Burisch, J.(1,3); Danish COVID-IBD Study Group
Created: Friday, 11 February 2022, 3:52 PM
DOP23: Myenteric plexitis and post-operative recurrence in Crohn’s disease: the role of enteric glial cells and ICAM-1
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

C. Le Berre*1, J. Pabois1, T. Durand1, E. Durieu1, M. Rolli-Derkinderen1, C. Bossard2, J. Podevin3, M. Neunlist1, I. Neveu1, P. Naveilhan1, A. Bourreille1,4

Created: Friday, 22 February 2019, 9:41 AM
DOP23: Myenteric plexitis and post-operative recurrence in Crohn’s disease: the role of enteric glial cells and ICAM-1
Year: 2019
Source: ECCO'19 Copenhagen
Authors: Catherine Le Berre
Created: Tuesday, 28 May 2019, 3:32 PM
Ileo caecal resection, Post operative complications, Post operative medical management, Post-operative IBD, Immunology, Lymphocyte, T cell
Files: 1